Lan Zhao to CRISPR-Cas Systems
This is a "connection" page, showing publications Lan Zhao has written about CRISPR-Cas Systems.
Connection Strength
1.587
-
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis. Mol Ther. 2024 Aug 07; 32(8):2549-2562.
Score: 0.937
-
Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis. Ann Rheum Dis. 2019 05; 78(5):676-682.
Score: 0.650